Malaria

GSK

Company2 trialsPhase 3711 people

Novartis

Company1 trialPhase 148 people

London School of Hygiene and Tropical Medicine

2 trialsPhase 41,470 people

Institute of Tropical Medicine, Belgium

1 trialPhase 41,370 people

Makerere University

1 trialPhase 4888 people

Centers for Disease Control and Prevention

1 trialPhase 4600 people

Wageningen University

1 trialPhase 3612 people

University of Ghana

1 trialPhase 3547 people